In vivo 4T1 breast cancer mouse orthotropic model revealed superior anticancerefficacy of PTX-siRNA-VEGF-NPs as compared with both PTX-NPs and siRNA-VEGF-NPsgroups. This evidence concerns the gene VEGFA and breast cancer.